---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Filgrastim - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/filgrastim
version: v1
---

# Filgrastim - NCI

# Filgrastim

Placeholder slot

(fil-GRAS-tim)

This page contains brief information about filgrastim and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Granix
Neupogen
Nivestym
Releuko
Zarxio

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=filgrastim&pagesize=20&page=1&audience=consumer)

## Use in Cancer

Filgrastim is approved to reduce the chance of [infection](/Common/PopUps/popDefinition.aspx?id=45364&version=Patient&language=English) in patients with:

- **[Neutropenia](/Common/PopUps/popDefinition.aspx?id=45361&version=Patient&language=English)** caused by some types of [chemotherapy](/Common/PopUps/popDefinition.aspx?id=45214&version=Patient&language=English), including:
- Chemotherapy for [acute myeloid leukemia](/Common/PopUps/popDefinition.aspx?id=46347&version=Patient&language=English).
- [Myeloablative chemotherapy](/Common/PopUps/popDefinition.aspx?id=650568&version=Patient&language=English) before a [bone marrow transplant](/Common/PopUps/popDefinition.aspx?id=45263&version=Patient&language=English) in patients with non-[myeloid](/Common/PopUps/popDefinition.aspx?id=46279&version=Patient&language=English) [cancer](/Common/PopUps/popDefinition.aspx?id=45333&version=Patient&language=English).
- [Myelosuppressive](/Common/PopUps/popDefinition.aspx?id=45796&version=Patient&language=English) chemotherapy in patients with non-myeloid cancer.

Filgrastim is also approved to help move [stem cells](/Common/PopUps/popDefinition.aspx?id=46598&version=Patient&language=English) from the [bone marrow](/Common/PopUps/popDefinition.aspx?id=45622&version=Patient&language=English) to the bloodstream so that they can be collected, stored, and then given back to the patient in [autologous stem cell transplantation](/Common/PopUps/popDefinition.aspx?id=270733&version=Patient&language=English).

Filgrastim is also approved to treat neutropenia that is not caused by cancer treatment.

Filgrastim is also available in a different form called [pegfilgrastim](/Common/PopUps/popDefinition.aspx?id=316080&version=Patient&language=English). For more information, see the Drug Information Summary for [Pegfilgrastim](https://www.cancer.gov/about-cancer/treatment/drugs/pegfilgrastim).

## More About Filgrastim

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/41057) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Filgrastim](https://medlineplus.gov/druginfo/meds/a692033.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Immune System Modulators](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/immune-system-modulators)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Filgrastim](https://www.cancer.gov/research/participate/clinical-trials/intervention/C1474) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
